secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viatris Inc (VTRS)
CIK:        0001792044
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296756
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viatris appoints Doretta Mistras as CFO effective March 1, 2024; Philippe Martin as Chief R&D Officer
--------------------------------------------------------------------------------

- Sanjeev Narula to step down as CFO on March 1, 2024; will receive severance of 2x base salary and target bonus.
- Theodora 'Doretta' Mistras, former Citigroup MD, appointed CFO effective March 1, 2024; base salary $825k, target bonus 100%, LTI 400%.
- Mistras receives $500k cash sign-on and $500k RSUs subject to vesting/repayment conditions.
- Philippe Martin appointed Chief R&D Officer; previously led development of Otezla and Zeposia at Celgene.
- Changes are part of Viatris's preparation for Phase 2 of its strategic plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792044/000119312523296756/0001193125-23-296756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792044/000119312523296756/d592995d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer